Colestipol/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: Creating Related Articles subpage) |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | <noinclude>{{subpages}}</noinclude> | ||
==Parent topics== | ==Parent topics== | ||
| Line 17: | Line 17: | ||
{{r|Hydrocortisone}} | {{r|Hydrocortisone}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Lovastatin}} | |||
{{r|Diabesity}} | |||
Latest revision as of 11:00, 30 July 2024
- See also changes related to Colestipol, or pages that link to Colestipol or to this page or whose text contains "Colestipol".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Colestipol. Needs checking by a human.
- Food and Drug Administration [r]: The agency of the United States Department of Health and Human Services responsible for regulating food, dietary supplements, drugs, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics. [e]
- Hydrocortisone [r]: The most important human glucocorticoid, a steroid hormone, produced by the adrenal cortex. [e]
- Lovastatin [r]: Type I statin and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor used to treat hypercholesterolemia. [e]
- Diabesity [r]: A term referring to the intricate relationship between type 2 diabetes and obesity. [e]